Hybrid argon plasma coagulation for the treatment of Barrett’s esophagus: A prospective, multicenter study

Table 1 Cohort demographics

Parameter	Research particpants, number of cases (%), n = 80
Age
≤ 50 yr	26 (32.5)
> 50 yr	54 (67.5)
Sex
Male	39 (48.75)
Female	41 (51.25)
Morphology of BE under endoscopy
Circumferential columnar epithelium	6 (7.5)
Tongue-like epithelium	38 (47.5)
Island-like epithelium	28 (35)
Other	8 (10)
Length of esophageal columnar epithelium
Short-segment BE (< 3 cm)	61 (76.25)
Long-segment BE (≥ 3 cm)	19 (23.75)
Accompanied by intestinal metaplasia
Yes	31 (39)
No	49 (61)

BE: Barrett’s esophagus.

Table 2 Correlation analysis between the length of esophageal columnar epithelium and therapeutic efficacy of ERBE argon plasma coagulation

	Short-segment BE (n = 61)	Long-segment BE (n = 19)	P value
Duration of the procedure (min)	9.93 ± 5.46	14.16 ± 8.56	0.013
Complications	0% (0/61)	10.53% (2/19)	1.000
Curative rate of BE	100% (39/39)	87.50% (14/16)	0.186

BE: Barrett’s esophagus.

Table 3 Correlation analysis between clinical expertise (years performing endoscopy) of endoscopists and therapeutic efficacy of ERBE argon plasma coagulation

	Attending physician (n = 28)	Senior physician (n = 52)	P value
Duration of the procedure (min)	11.93 ± 7.81	10.40 ± 5.73	0.322
Complications	7.12% (2/28)	0% (0/52)	0.230
Curative rate of BE	95.45% (21/22)	96.97% (32/33)	1.000

BE: Barrett’s esophagus.